What is certain is that the downregulation of BMPR2 is critical, since impaired BMP-related signaling pathway is a characteristic mechanism of PAH, regardless of genetic pathogenesis and in the absence of the known disease mutations. The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.